EP2090579 - Substituted heteroarylamide diazepinopyrimidone derivatives [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.12.2010 Database last updated on 31.08.2024 | Most recent event Tooltip | 10.12.2010 | Application deemed to be withdrawn | published on 12.01.2011 [2011/02] | Applicant(s) | For all designated states Sanofi-Aventis 174, Avenue de France 75013 Paris / FR | For all designated states Mitsubishi Tanabe Pharma Corporation 2-6-18 Kitahama, Chuo-Ku Osaka-shi Osaka 541-8505 / JP | [N/P] |
Former [2010/01] | For all designated states Sanofi-Aventis 174 Avenue de France 75013 Paris / FR | ||
For all designated states Mitsubishi Tanabe Pharma Corporation 2-6-18 Kitahama, Chuo-Ku Osaka-Shi Osaka 541-8505 / JP | |||
Former [2009/34] | For all designated states Sanofi-Aventis 174 Avenue de France 75013 Paris / FR | ||
For all designated states Mitsubishi Tanabe Pharma Corporation 2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi Osaka 541-8505 / JP | Inventor(s) | 01 /
Fayol, Aude sanofi-aventis Dépt Brevets 174 avenue de France 75013 Paris / FR | 02 /
Lochead, Alistair sanofi-aventis Dépt Brevets 174 avenue de France 75013 Paris / FR | 03 /
Saady, Mourad sanofi-aventis Dépt Brevets 174 avenue de France 75013 Paris / FR | 04 /
Vache, Julien sanofi-aventis Dépt Brevets 174 avenue de France 75013 Paris / FR | 05 /
Yaiche, Philippe sanofi-aventis Dépt Brevets 174 avenue de France 75013 Paris / FR | [2009/34] | Representative(s) | Morel-Pécheux, Muriel, et al Sanofi Département Brevets 54, rue La Boétie 75008 Paris / FR | [N/P] |
Former [2009/34] | Morel-Pécheux, Muriel, et al Sanofi-Aventis Département Brevets 174 avenue de France 75013 Paris / FR | Application number, filing date | 08290076.2 | 29.01.2008 | [2009/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2090579 | Date: | 19.08.2009 | Language: | EN | [2009/34] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 21.07.2008 | Classification | IPC: | C07D487/04, C07D403/04, A61K31/519 | [2009/34] | CPC: |
C07D487/04 (EP,US);
A61P13/12 (EP);
A61P17/00 (EP);
A61P17/14 (EP);
A61P19/00 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P21/02 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P27/06 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
A61P33/06 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07D519/00 (EP,US)
(-)
| Designated contracting states | FR [2010/17] |
Former [2009/34] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | Substituierte Heteroarylamiddiazepinopyrimidon-Derivate | [2009/34] | English: | Substituted heteroarylamide diazepinopyrimidone derivatives | [2009/34] | French: | Dérivés d'hétéroarylamide diazépinopyrimidone substitués | [2009/34] | Examination procedure | 19.02.2010 | Examination requested [2010/13] | 20.02.2010 | Loss of particular rights, legal effect: designated state(s) | 15.03.2010 | Despatch of a communication from the examining division (Time limit: M04) | 26.03.2010 | Despatch of communication of loss of particular rights: designated state(s) AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | 27.07.2010 | Application deemed to be withdrawn, date of legal effect [2011/02] | 27.08.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/02] | Fees paid | Renewal fee | 13.01.2010 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]EP1557417 (SANOFI AVENTIS [FR], et al) [A] 1-17 * the whole document *; | [A]EP1790649 (SANOFI AVENTIS [FR], et al) [A] 1-17 * the whole document *; | [A] - ROBERT M KYPTA, "GSK-3 inhibitors and their potential in the treatment of Alzheimer's disease", EXPERT OPINION ON THERAPEUTICAL PATENTS, (2005), vol. 15, no. 10, pages 1315 - 1331, XP002486909 [A] 1-17 * the whole document * DOI: http://dx.doi.org/10.1517/13543776.15.10.1315 | by applicant | DE2705582 | WO9716430 | - NATURE, (200406), vol. 3, pages 479 - 487 | - TRENDS IN PHARMACOLOGICAL SCIENCES, (20040909), vol. 25, pages 471 - 480 | - JOURNAL OF NEUROCHEMISTRY, (2004), vol. 89, pages 1313 - 1317 | - MEDICINAL RESEARCH REVIEWS, (2002), vol. 22, no. 4, pages 373 - 384 | - THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2002), vol. 277, no. 37, pages 33791 - 33798 | - BIOCHEM. J., (2003), vol. 372, pages 129 - 136 | - EUROPEAN JOURNAL OF NEUROSCIENCE, (2005), vol. 22, pages 301 - 309 | - NATURE MEDICINE, (2004), vol. 10, pages 55 - 63 | - BIOCHIMICA ET BIOPHYSICAACTA, (2004), vol. 1697, pages 181 - 196 | - J. BIOL. CHEM., (2008), vol. 283, pages 358 - 366 | - TETRAHEDRON LETTERS, (1989), vol. 30, no. 45, pages 6113 - 6116 | - TETRAHEDRON LETTERS, vol. 32, no. 22, pages 2469 - 2470 | - WOODGETT, J. R., ANALYTICAL BIOCHEMISTRY, (1989), vol. 180, pages 237 - 241 |